Bus S, de Haan R, Vermeulen M, van Schaik I, Eftimov F
Cochrane Database Syst Rev. 2024; 2:CD001797.
PMID: 38353301
PMC: 10865446.
DOI: 10.1002/14651858.CD001797.pub4.
Sarkozy A, Sa M, Ridout D, Fernandez-Garcia M, Distefano M, Main M
Neurology. 2023; 101(15):e1495-e1508.
PMID: 37643885
PMC: 10585689.
DOI: 10.1212/WNL.0000000000207723.
Merlini L, Sabatelli P, Gualandi F, Redivo E, Di Martino A, Faldini C
Int J Mol Sci. 2023; 24(15).
PMID: 37569848
PMC: 10420187.
DOI: 10.3390/ijms241512474.
Schreiber-Katz O, Siegler H, Wieselmann G, Kumpe M, Ranxha G, Petri S
Sci Rep. 2023; 13(1):6240.
PMID: 37069197
PMC: 10107562.
DOI: 10.1038/s41598-023-31617-5.
Carvalho P, Regis T, Faical A, Lago R, Terse-Ramos R, Acosta A
J Pediatr (Rio J). 2022; 99(1):94-98.
PMID: 35940209
PMC: 9875273.
DOI: 10.1016/j.jped.2022.07.002.
First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy.
Xie Z, Sun C, Liu C, Chu X, Gang Q, Yu M
Front Pediatr. 2022; 10:900280.
PMID: 35813381
PMC: 9257024.
DOI: 10.3389/fped.2022.900280.
Magnetic resonance imaging pattern variability in dysferlinopathy.
Bardakov S, Tsargush V, Carlier P, Nikitin S, Kurbatov S, Titova A
Acta Myol. 2022; 40(4):158-171.
PMID: 35047756
PMC: 8744010.
DOI: 10.36185/2532-1900-059.
Effects of lumbar lordosis increment on gait deteriorations in ambulant boys with Duchenne Muscular Dystrophy: A cross-sectional study.
Filiz M, Toraman N, Kutluk M, Filiz S, Koldas Dogan S, Cakir T
Braz J Phys Ther. 2021; 25(6):749-755.
PMID: 34119442
PMC: 8721072.
DOI: 10.1016/j.bjpt.2021.05.001.
Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.
Merlini L, Cecconi I, Parmeggiani A, Cordelli D, Dormi A
Acta Myol. 2021; 39(4):200-206.
PMID: 33458575
PMC: 7783426.
DOI: 10.36185/2532-1900-023.
Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy.
Zhang J, Meng Q, Zhong J, Zhang M, Qin X, Ni X
Front Neurol. 2020; 11:563609.
PMID: 33071947
PMC: 7530632.
DOI: 10.3389/fneur.2020.563609.
Manifesting carriers of X-linked myotubular myopathy: Genetic modifiers modulating the phenotype.
Souza L, Almeida C, Yamamoto G, de Cassia Mingroni Pavanello R, Gurgel-Giannetti J, da Costa S
Neurol Genet. 2020; 6(5):e513.
PMID: 33062893
PMC: 7524580.
DOI: 10.1212/NXG.0000000000000513.
Selenoprotein N-related myopathy: a retrospective natural history study to guide clinical trials.
Silwal A, Sarkozy A, Scoto M, Ridout D, Schmidt A, Laverty A
Ann Clin Transl Neurol. 2020; 7(11):2288-2296.
PMID: 33037864
PMC: 7664282.
DOI: 10.1002/acn3.51218.
A 5-year clinical follow-up study from the Italian National Registry for FSHD.
Vercelli L, Mele F, Ruggiero L, Sera F, Tripodi S, Ricci G
J Neurol. 2020; 268(1):356-366.
PMID: 32813049
PMC: 7815626.
DOI: 10.1007/s00415-020-10144-7.
Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.
Muntoni F, Domingos J, Manzur A, Mayhew A, Guglieri M, Sajeev G
PLoS One. 2019; 14(9):e0221097.
PMID: 31479456
PMC: 6719875.
DOI: 10.1371/journal.pone.0221097.
Magnetic Resonance Imaging Findings in the Muscle Tissue of Patients with Limb Girdle Muscular Dystrophy Type 2I Harboring the Founder Mutation c.545A>G in the Gene.
Xie Z, Xiao J, Zheng Y, Wang Z, Yuan Y
Biomed Res Int. 2018; 2018:3710814.
PMID: 30003095
PMC: 5996470.
DOI: 10.1155/2018/3710814.
Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy.
Capelini C, Silva T, Tonks J, Watson S, Alvarez M, Menezes L
Neuropsychiatr Dis Treat. 2017; 13:2209-2217.
PMID: 28860778
PMC: 5571857.
DOI: 10.2147/NDT.S125466.
Patients with Duchenne and Becker muscular dystrophies are not more asymmetrical than healthy controls on timed performance of upper limb tasks.
Artilheiro M, Sa C, Favero F, Caromano F, Voos M
Braz J Med Biol Res. 2017; 50(8):e6031.
PMID: 28746422
PMC: 5525194.
DOI: 10.1590/1414-431X20176031.
Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
Elverman M, Goddard M, Mack D, Snyder J, Lawlor M, Meng H
Muscle Nerve. 2017; 56(5):943-953.
PMID: 28370029
PMC: 5620115.
DOI: 10.1002/mus.25658.
Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?.
Buckon C, Sienko S, Bagley A, Sison-Williamson M, Fowler E, Staudt L
PLoS Curr. 2016; 8.
PMID: 27500011
PMC: 4956479.
DOI: 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0.
Corticosteroids for the treatment of Duchenne muscular dystrophy.
Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur A
Cochrane Database Syst Rev. 2016; (5):CD003725.
PMID: 27149418
PMC: 8580515.
DOI: 10.1002/14651858.CD003725.pub4.